October

October 20, 2014

Therapeutic insights into making the highly efficient cardiomyocyte-like cells from differentiated cells: Pro-inflammatory protein IL-13 inhibits cardiac reprogramming by increasing Snai expression, 20/October/2014, 6.43 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan,  Therapeutic insights into making the highly efficient cardiomyocyte-like cells from differentiated cells: Pro-inflammatory protein […]
October 20, 2014

Mechanistic & therapeutic insights into tumorigenesis: SNAI2 increases the expression of MiR-17-92 via down regulation of its target gene, 20/October/2014, 6.39 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Citation: Boominathan, Mechanistic & therapeutic insights into tumorigenesis: SNAI2 increases the expression of MiR-17-92  via down regulation of its target gene, 20/October/2014, […]
October 20, 2014

MiRNA-based therapy for Human Cancer: MiRNA-185 suppresses the expression of Tripeptidyl Peptidase 1 (TPP1) via down regulation of its target genes, 20/October/2014, 6.17 am

The 1989 Nobel prize winner in Chemistry, Prof. Thomas R. Cech from the University of Colorado BioFrontiers Institute, USA has published a research paper in the 13 December 2012 Nature (492(7428):285-9; I.F: >42) stating that “The TEL patch of telomere protein TPP1 mediates telomerase […]
October 20, 2014

MiRNA-based therapy for Alzhemer’s disease and tauopathies: MiRNA-520c decreases tau phosphorylation and ameliorates tau pathology via down regulation of its target gene, 20/October/2014, 6.13 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, L., MiRNA-based therapy for Alzhemer’s disease and tauopathies: MiRNA-520c decreases tau phosphorylation and ameliorates tau pathology via […]